Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loxo Oncology IncfiledCriticalLoxo Oncology Inc
Publication of CL2019002239A1publicationCriticalpatent/CL2019002239A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
UN MÉTODO PARA TRATAI UN C4NCER PEDIAITRICO EN UN SUJETO QUE LO NECESITE. EL MÉTODO INCLUYE ADMINISTRAR AL SUJETO UNA CANTIDAD TERAPÉUTICAMENTE EFECTIVA DE (S)-N (5-R)-2 -(2,5 DIFLUOROFENIL) PIRROLIDIN-1 -IL)-PIRAZOLO ( 1,5 A)PIRIMIDIIN- 3-IL)-3-HIDROXIPIRROLIDIN- 1 CARBOXAMIDA, O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DE LA MISMA, O UNA COMBINACIÓN DE LAS MISMAS.A METHOD TO TREAT A PEDIAITRIC C4NCER IN A SUBJECT IN NEED. THE METHOD INCLUDES ADMINISTERING THE SUBJECT A THERAPEUTICALLY EFFECTIVE AMOUNT OF (S) -N (5-R) -2 - (2,5 DIFLUOROPHENYL) PYRROLIDIN-1 -IL) -PIRAZOLE (1.5 A) PYRIMIDIIN-3-IL) -3-HYDROXYPYRROLIDINE- 1 CARBOXAMIDE, OR A PHARMACEUTICALLY ACCEPTABLE SALT OF IT, OR A COMBINATION OF THEM.
CL2019002239A2016-04-042019-08-08
Pediatric Cancer Treatment Methods. (divisional request 201802807)
CL2019002239A1
(en)